Incyte Corp

XMUN:ICY

Business Description

Sector

Health Care

Industry

Biotechnology

Headquarters

United States of America US

Employees

2 844

IPO date

Dec 6, 1993

Incyte Corp is a biopharmaceutical company that discovers, develops, and sells prescription medicines, mainly for cancer and immune-related diseases. Its best-known products include treatments used by specialists in oncology and dermatology, where doctors prescribe the drugs to patients with conditions such as blood cancers, graft-versus-host disease, and inflammatory skin disorders.

The company makes money mainly by selling its own branded medicines and by earning partnership income from drug collaborations, such as royalties and milestone payments from partners that help develop or market certain products. Its customers are not consumers buying over the counter; they are hospitals, clinics, specialty pharmacies, and the healthcare systems that pay for prescription drugs.

What makes Incyte different is that it sits in the middle of drug discovery and commercialization. It focuses on finding medicines in-house, advancing them through clinical testing, and then either selling them itself in selected markets or sharing them with partners. That model lets the company build a portfolio of proprietary drugs while also using partnerships to extend the reach of its pipeline.